NCT00405509

Brief Summary

This study examines the cold processes of children aged 6 to less than 14. Children will be seen by the study staff 6 days in a row during the course of their naturally-acquired colds. Nasal secretions will be examined for chemicals that the body creates during a cold. Skin cells will be collected by brushing the inside of the child's cheek with a small brush. The cells will be examined for genes that may hold control the creation of these chemicals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2006

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 30, 2006

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2009

Completed
5.7 years until next milestone

Results Posted

Study results publicly available

September 30, 2014

Completed
Last Updated

August 19, 2016

Status Verified

July 1, 2016

Enrollment Period

2.3 years

First QC Date

November 28, 2006

Results QC Date

May 8, 2009

Last Update Submit

July 20, 2016

Conditions

Keywords

Upper Respiratory InfectionCommon Cold

Outcome Measures

Primary Outcomes (1)

  • Local Leukotriene Levels

    nasal secretions were collected once a day for the first six days of the respiratory infection and on day 30 then measured for leukotriene levels

    once a day for 6 days and on day 30

Secondary Outcomes (4)

  • Nasal Secretion Weights

    each day for 5 days

  • Severity of Symptom Scores - COUGH

    once a day for six days and on day 30

  • Severity of Symptom Score - NASAL CONGESTION

    once a day for six days and on day 30

  • Severity of Symptom Score - SNEEZING

    once a day for six days and on Day 30

Study Arms (2)

Confirmed respiratory virus

Unconfirmed respiratory infection

Eligibility Criteria

Age6 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Male and Female subjects ages 6 to under 14 years with common cold symptoms of less than 24 hours in duration.

You may qualify if:

  • Children 6 to \< 14 years of age.
  • Common cold symptoms for less than 24 hours.
  • At least 2 of the following 8 symptoms: cough, headache, hoarseness, muscle ache, nasal drainage, nasal congestion, scratchy throat, and sneezing.

You may not qualify if:

  • Investigational medication in past 30 days.
  • History of persistent asthma or other chronic diseases.
  • Patients with nasal ulcers within the past 1 month, nasal surgery within the past 6 months, nasal trauma within the past 2 months or presence of nasal polyps or nasal deformities causing significant nasal obstruction.
  • Patients with evidence of significant nasal septal deviation.
  • Patients with a positive rapid antigen test for streptococcal infection.
  • Common cold symptoms for more than 24 hours.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Allegheny General Hospital

Pittsburgh, Pennsylvania, 15212, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Buccal brushing for genotyping

MeSH Terms

Conditions

Respiratory Tract InfectionsCommon Cold

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract DiseasesPicornaviridae InfectionsRNA Virus InfectionsVirus Diseases

Limitations and Caveats

Respiratory viruses were not detected in approximately 2/3 of the enrolled subjects. Future studies will need to apply more stringent inclusion/exclusion criteria to circumvent this problem.

Results Point of Contact

Title
Deborah Gentile, MD
Organization
Allegheny General Hospital

Study Officials

  • Deborah Gentile, MD

    West Penn Allegheny Health System

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Research, Allergy and Asthma Institute

Study Record Dates

First Submitted

November 28, 2006

First Posted

November 30, 2006

Study Start

October 1, 2006

Primary Completion

January 1, 2009

Study Completion

January 1, 2009

Last Updated

August 19, 2016

Results First Posted

September 30, 2014

Record last verified: 2016-07

Locations